Security key
07782B104
BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share (BLTE)
CUSIP: 07782B104
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Ordinary shares, par value US$0.0001 per share
- Total 13F shares
- 58,112
- Total 13F value
- $2,229,758
- Share change
- -96,997
- SEC-reported price per share
- $38.37
- Number of holders
- 11
- Value change
- -$4,083,463
- Number of buys
- 2
- Number of sells
- 14
- Shares outstanding
- 40,449,516
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
11
Top holders
10
BLTE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BELITE BIO, INC SEC filings
BELITE BIO, INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 07782B104
Recent filing periods:
Ownership snapshot
Top reported holders of BLTE - BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 0.09%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 0.09%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
0.09%
MORGAN STANLEY
0.06%
STATE STREET CORP
0.04%
Cubist Systematic Strategies, LLC
0.04%
MARSHALL WACE, LLP
0.04%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.09%
|
$1,647,000
36,000 shares
|
— | 31 Dec 2023 |
| MORGAN STANLEY |
13F
Company
|
0.06%
|
$1,025,761
22,421 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
0.04%
|
$803,233
17,557 shares
|
— | 31 Dec 2023 |
| Cubist Systematic Strategies, LLC |
13F
Company
|
0.04%
|
$772,352
16,882 shares
|
— | 31 Dec 2023 |
| MARSHALL WACE, LLP |
13F
Company
|
0.04%
|
$732,503
16,011 shares
|
— | 31 Dec 2023 |
| JPMORGAN CHASE & CO |
13F
Company
|
0.04%
|
$652,715
14,267 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
58,112
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2026 Across Filers
Q1 2026 holders
75
Q1 2024 holders
11
Holder diff
-64
| Investor | Q1 2026 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend